Presented by PRMA Oncology experts, Founding Partner David Sykes and Associate Director Clare Jones.
What will I learn from this webinar?
Immunotherapies are a rapidly evolving class of therapies that in some cases could provide dramatic increases in survival. To realize fully the potential of such products, manufacturers need to anticipate the market access environment into which they will be launched and consider innovative ways to communicate the value and positioning of their product to payers.
Who is this webinar for?
Market access success requires a cross-functional approach involving multiple stakeholders. This webinar will be valuable to anyone in HEOR, market access, clinical, medical, regulatory, or commercial roles.
Will I be able to ask questions?
Yes; this is intended to be an interactive webinar. You will be able to raise questions during the webinar, which we will answer at the end of the session or one of our team will follow up afterwards.
Not sure you can make it?
You should still register. We will provide a recording of the webinar afterwards to all registrants, even if they don’t make it on the day, and we will be pleased to answer your questions by email or telephone.
